{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:15:19Z","timestamp":1792012519529,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.vaccine.2022.08.008","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T08:12:19Z","timestamp":1661155939000},"page":"A19-A24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S1","title":["Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020"],"prefix":"10.1016","volume":"41","author":[{"given":"Grace R","family":"Macklin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Tallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal A","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C","family":"Grassly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousmane M","family":"Diop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.08.008_b0005","unstructured":"Global Polio Eradication Initiative. The Polio Eradication & Endgame Strategic Plan 2013-2018 Geneva: World Health Organisation2013. p. http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf."},{"key":"10.1016\/j.vaccine.2022.08.008_b0010","unstructured":"Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 - conclusions and recommendations. Wkly Epidemiol Rec. 2013;88(1):1-16."},{"issue":"7","key":"10.1016\/j.vaccine.2022.08.008_b0015","doi-asserted-by":"crossref","first-page":"e1005728","DOI":"10.1371\/journal.ppat.1005728","article-title":"Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame","volume":"12","author":"Pons-Salort","year":"2016","journal-title":"PLoS Pathog"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2022.08.008_b0020","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1093\/infdis\/jit845","article-title":"Modeling the dynamics of oral poliovirus vaccine cessation","volume":"210","author":"Thompson","year":"2014","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.08.008_b0025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1716677","article-title":"Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine","volume":"379","author":"Blake","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.08.008_b0030","unstructured":"Global Polio Eradication Initiative. Standard Operating Procedures: Responding to a poliovirus event or outbreak Geneva2020 [updated March 2020. Version 3.1:[Available from: http:\/\/polioeradication.org\/wp-content\/uploads\/2020\/04\/POL-SOP-V3.1-20200424.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.008_b0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/JVI.01532-15","article-title":"Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria","volume":"90","author":"Famulare","year":"2016","journal-title":"J Virol"},{"issue":"42","key":"10.1016\/j.vaccine.2022.08.008_b0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6742a5","article-title":"Update on Vaccine-Derived Polioviruses - Worldwide, January 2017-June 2018","volume":"67","author":"Jorba","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.008_b0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12879-017-2443-4","article-title":"An assessment of the geographical risks of wild and vaccine-derived poliomyelitis outbreaks in Africa and Asia","volume":"17","author":"O'Reilly","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"6489","key":"10.1016\/j.vaccine.2022.08.008_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"issue":"suppl 1","key":"10.1016\/j.vaccine.2022.08.008_b0055","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1093\/infdis\/jiu384","article-title":"Environmental surveillance for polioviruses in the Global Polio Eradication Initiative","volume":"210","author":"Asghar","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.008_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01103","article-title":"Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry","volume":"8","author":"Macklin","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.08.008_b0065","unstructured":"World Health Organization. Polio laboratory manual, 4th edition. Geneva: World Health Organisation; 2004 [Available from: http:\/\/polioeradication.org\/wp-content\/uploads\/2017\/05\/Polio_Lab_Manual04.pdf."},{"key":"10.1016\/j.vaccine.2022.08.008_b0070","unstructured":"Global Polio Eradication Initiative. Polio environmental surveillance expansion plan. Geneva2015 [Available from: http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/GPLN_ExpansionPlanES.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.008_b0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2022.08.008_b0080","unstructured":"Statement of the Twenty-Seventh Polio IHR Emergency Committee [press release]. World Health Organisation,, 19 February 2021 2021."},{"issue":"10","key":"10.1016\/j.vaccine.2022.08.008_b0085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S1473-3099(19)30301-9","article-title":"Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis","volume":"19","author":"Macklin","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2022.08.008_b0090","first-page":"585","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, October 2020\u2013conclusions and recommendations","volume":"95","author":"World Health Organization","year":"2020","journal-title":"Wkly Epidemiol Rec"},{"issue":"22","key":"10.1016\/j.vaccine.2022.08.008_b0095","first-page":"197","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, 22\u201324 March 2021: conclusions and recommendations","volume":"96","author":"World Health Organization","year":"2021","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2022.08.008_b0100","unstructured":"World Health Organisation. Emergency Use Listing Procedure, Version 9 Geneva, Switzerland: World Health Organisation; 2020 [Available from: https:\/\/extranet.who.int\/prequal\/sites\/default\/files\/documents\/EUL_Procedure_Jan2020.pdf."},{"issue":"5","key":"10.1016\/j.vaccine.2022.08.008_b0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.chom.2020.04.003","article-title":"Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence","volume":"27","author":"Yeh","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.008_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-0176-7","article-title":"Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization","volume":"5","author":"Konopka-Anstadt","year":"2020","journal-title":"npj Vaccines"},{"issue":"10193","key":"10.1016\/j.vaccine.2022.08.008_b0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(19)31279-6","article-title":"The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study","volume":"394","author":"Van Damme","year":"2019","journal-title":"The Lancet"},{"issue":"10268","key":"10.1016\/j.vaccine.2022.08.008_b0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(20)32541-1","article-title":"Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials","volume":"397","author":"De Coster","year":"2021","journal-title":"Lancet"},{"issue":"10268","key":"10.1016\/j.vaccine.2022.08.008_b0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)32540-X","article-title":"Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials","volume":"397","author":"S\u00e1ez-Llorens","year":"2021","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.vaccine.2022.08.008_b0130","first-page":"241","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, 31 March\u20131 April 2020: conclusions and recommendations","volume":"95","author":"World Health Organization","year":"2020","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:25:25Z","timestamp":1759404325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22009628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":26,"alternative-id":["S0264410X22009628"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}